🇺🇸 FDA
Patent

US 11384098

Pyrrolobenzodiazepine-antibody conjugates

granted A61KA61K45/06A61K47/68035

Quick answer

US patent 11384098 (Pyrrolobenzodiazepine-antibody conjugates) held by ADC THERAPEUTICS SA expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ADC THERAPEUTICS SA
Grant date
Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K45/06, A61K47/68035, A61K47/6849, A61K47/6861